NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVEUnusual Whales·Aug 20 at 03:06 PMNXGL+1.94%
Nexgel’s Celularity Deal: Execution, Integration, and Profitability Risks from $13.3 Million Biomaterials AcquisitionTip Ranks·Aug 18 at 01:00 AMCELU+0.72%CELUW0.00%
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga_article·Aug 17 at 12:06 PMNBTX-8.50%OSRHW0.00%
NXGL: Q2 revenue reached $3.69M with a $2.87M net loss; integration and expansion efforts continueQuartr·Aug 17 at 07:25 AMNXGL+1.94%
Nexgel | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 3.69 MEarnings Watch·Aug 17 at 07:17 AMNXGL+1.94%
NexGel Q2 FY26 gross profit falls 11.84% to $1.11 million; revenue rises 27.8% to $3.69 millionPUBT·Aug 17 at 05:36 AMNXGL+1.94%
NXGL: Q2 2026 revenue up 27.8% to $3.7M, but net loss widened and going concern risks persistQuartr·Aug 17 at 05:06 AMNXGL+1.94%
U.S. stock market midday update: Nexgel up 18.66%! Medical innovation + influx of funds, short-term increase exceeds 50%Price Alert·Aug 14 at 10:08 AMNXGL+1.94%
Forget Big Tech: The Market's 'Misfits' Tell the Real Story of the 2026 EconomyGlobal Report·Aug 11 at 04:43 AMVLY+0.53%FIVN+0.61%
NexGel shareholders constrain structural changes at annual meetingTip Ranks·Aug 5 at 04:53 PMNXGL+1.94%
